Long-term efficacy and tolerability of quetiapine in patients with schizophrenia who switched from other antipsychotics because of inadequate therapeutic response—a prospective open-label study

被引：0
|
作者：
Naoki Hashimoto
Atsuhito Toyomaki
Minoru Honda
Satoru Miyano
Nobuyuki Nitta
Hiroyuki Sawayama
Yasufumi Sugawara
Keiichi Uemura
Noriko Tsukamoto
Tsukasa Koyama
Ichiro Kusumi
机构：
[1] Hokkaido University Graduate School of Medicine,Department of Psychiatry
[2] Child and Adolescent Psychiatry,Department of Psychiatry
[3] Department of Psychiatry University of California,undefined
[4] Honda Memorial Hospital,undefined
[5] Teine Hospital,undefined
[6] Sapporo Hanazono Hospital,undefined
[7] San-ai Hospital,undefined
[8] Psychiatric Medical Center,undefined
[9] Sapporo City General Hospital,undefined
[10] Hakodate Watanabe Hospital,undefined
[11] Oyachi Hospital,undefined
来源：
Annals of General Psychiatry | / 14卷
关键词：
Schizophrenia; Quetiapine; Switching; Antipsychotic; Negative symptom; Cognitive impairment; Treatment resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] A prospective, controlled, open-label, long-term study of the efficacy and tolerability of topiramate in the prophylaxis of chronic tension-type headache
    Lampl, C
    Marecek, S
    CEPHALALGIA, 2005, 25 (10) : 941 - 941
  • [32] A prospective, controlled, open-label, long-term study of the efficacy and tolerability of topiramate in the prophylaxis of chronic tension-type headache
    Lampl, C
    Marecek, S
    Bendtsen, L
    NEUROLOGY, 2006, 66 (05) : A140 - A141
  • [33] Long-Term Efficacy and Safety of Brexpiprazole in Elderly Japanese Patients with Schizophrenia: A Subgroup Analysis of an Open-Label Study
    Inada, Ken
    Yamada, Sakiko
    Akiyoshi, Hisashi
    Kojima, Yoshitsugu
    Iwashita, Shuichi
    Ishigooka, Jun
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2020, 16 : 2267 - 2275
  • [34] The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: Results of a prospective, multicenter, open-label study
    Gottlieb, Alice B.
    Kalb, Robert E.
    Blauvelt, Andrew
    Heffernan, Michael P.
    Sofen, Howard L.
    Ferris, Laura Korb
    Kerdel, Francisco A.
    Calabro, Stephen
    Wang, Jim
    Kerkmann, Urs
    Chevrier, Marc
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (04) : 642 - 650
  • [35] Quetiapine demonstrates good tolerability and is associated with improvements in extrapyramidal symptoms in patients with schizophrenia switched from other antipsychotics: results of a naturalistic study
    Hellewell, Jonathan S. E.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (02) : 112 - 122
  • [36] Blonanserin Augmentation of Atypical Antipsychotics in Patients with Schizophrenia-Who Benefits from Blonanserin Augmentation?: An Open-Label, Prospective, Multicenter Study
    Woo, Young Sup
    Park, Joo Eon
    Kim, Do-Hoon
    Sohn, Inki
    Hwang, Tae-Yeon
    Park, Young-Min
    Jon, Duk-In
    Jeong, Jong-Hyun
    Bahk, Won-Myong
    PSYCHIATRY INVESTIGATION, 2016, 13 (04) : 458 - 467
  • [37] Safety and tolerability of plecanatide in patients with chronic idiopathic constipation: long-term evidence from an open-label study
    Barish, Charles F.
    Griffin, Patrick
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (04) : 751 - 755
  • [38] LONG-TERM SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PALIPERIDONE PALMITATE: A ONE-YEAR OPEN-LABEL STUDY IN PATIENTS WITH SCHIZOPHRENIA.
    Coppola, D.
    Liu, Y.
    Gopal, S.
    Remmerie, B.
    Samtani, M.
    Pandina, G.
    Hough, D.
    Nuamah, I.
    Sulaiman, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S25 - S25
  • [39] Safety and Tolerability of Plecanatide in Patients with Chronic Idiopathic Constipation: Long-term Evidence from an Open-Label Study
    De La Portilla, Marianela
    Barrow, Laura
    Hickey, Bernadette
    Griffin, Patrick
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S248 - S249
  • [40] Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, open-label study in stable patients switched from typical and atypical oral antipsychotics
    Cetin, M
    Ebrinc, S
    Basoglu, C
    Semiz, UB
    Gunay, H
    Iyisoy, MS
    Ergun, BM
    Gunes, C
    Sahan, A
    Oguz, M
    Noyan, O
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S134 - S135
12345